NFSG
ANIP icon

Newbridge Financial Services Group’s ANI Pharmaceuticals ANIP Stock Holding History

Newbridge Financial Services Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.7K Hold
600
– – 0.01% 491
2026
Q1 		$46.1K Hold
600
– – 0.01% 436
2025
Q4 		$47.4K Hold
600
– – 0.01% 443
2025
Q3 		$55K Hold
600
– – 0.01% 493
2025
Q2 		$39.1K Buy
600
+400
+200% +$26K 0.01% 554
2025
Q1 		$13.4K Hold
200
– – ﹤0.01% 630
2024
Q4 		$11.1K Hold
200
– – ﹤0.01% 713
2024
Q3 		$11.9K Hold
200
– – ﹤0.01% 416
2024
Q2 		$12.7K Hold
200
– – ﹤0.01% 659
2024
Q1 		$13.8K Hold
200
– – 0.01% 691
2023
Q4 		$11K Hold
200
– – 0.01% 714
2023
Q3 		$11.6K Buy
+200
New +$11.5K 0.01% 784

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Newbridge Financial Services Group's ANIP Position: Q2 2026 in Review

Newbridge Financial Services Group held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 600 shares worth $49.7K. The position accounts for 0.01% of the portfolio, ranked #491.

Newbridge Financial Services Group first reported a position in ANIP in Q3 2023 and has held it in 12 quarters since. The position peaked at $55K in Q3 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Newbridge Financial Services Group held 600 shares of ANI Pharmaceuticals worth $49.7K as of Q2 2026.
  • Newbridge Financial Services Group left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up 0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #491 holding.
  • Newbridge Financial Services Group first reported a position in ANI Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Newbridge Financial Services Group's ANI Pharmaceuticals position peaked at $55K in Q3 2025.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.